JUNS logo

Jupiter Neurosciences (JUNS) Operating Profit

JUNS Annual Operating Profit

-$3.87 M
-$438.40 K-12.77%

01 December 2023

JUNS Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

JUNS Quarterly Operating Profit

-$493.55 K
+$63.55 K+11.41%

30 September 2024

JUNS Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

JUNS TTM Operating Profit

-$2.16 M
+$948.58 K+30.54%

30 September 2024

JUNS TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

JUNS Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-12.8%+65.8%+47.9%
3 y3 years-109.0%+28.8%+50.7%
5 y5 years-77.8%+43.1%+0.5%

JUNS Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.8%+0.9%at high+70.7%at high+52.6%
5 y5-year-109.0%+0.9%-115.7%+70.7%-252.8%+52.6%
alltimeall time-109.0%+0.9%-115.7%+70.7%-252.8%+52.6%

Jupiter Neurosciences Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$493.55 K(-11.4%)
-$2.16 M(-30.5%)
June 2024
-
-$557.10 K(-2.4%)
-$3.11 M(-8.2%)
Mar 2024
-
-$570.70 K(+6.5%)
-$3.38 M(-12.4%)
Dec 2023
-
-$535.64 K(-62.9%)
-$3.86 M(-6.7%)
Dec 2023
-$3.87 M(+12.8%)
-
-
Sept 2023
-
-$1.44 M(+72.9%)
-$4.14 M(+10.4%)
June 2023
-
-$833.90 K(-20.4%)
-$3.75 M(+3.9%)
Mar 2023
-
-$1.05 M(+28.8%)
-$3.61 M(+5.1%)
Dec 2022
-$3.43 M
-$813.50 K(-22.6%)
-$3.43 M(-20.3%)
DateAnnualQuarterlyTTM
Sept 2022
-
-$1.05 M(+51.6%)
-$4.31 M(-1.7%)
June 2022
-
-$693.60 K(-20.6%)
-$4.38 M(-3.8%)
Mar 2022
-
-$873.70 K(-48.2%)
-$4.55 M(+16.5%)
Dec 2021
-$3.91 M(+111.0%)
-$1.69 M(+50.0%)
-$3.91 M(+45.7%)
Sept 2021
-
-$1.12 M(+29.6%)
-$2.68 M(+23.7%)
June 2021
-
-$867.30 K(+279.1%)
-$2.17 M(+66.7%)
Mar 2021
-
-$228.80 K(-50.3%)
-$1.30 M(+21.3%)
Dec 2020
-$1.85 M(-14.9%)
-$460.70 K(-24.6%)
-$1.07 M(+75.4%)
Sept 2020
-
-$611.40 K
-$611.40 K
Dec 2019
-$2.18 M
-
-

FAQ

  • What is Jupiter Neurosciences annual operaing income?
  • What is the all time high annual operating profit for Jupiter Neurosciences?
  • What is Jupiter Neurosciences annual operating profit year-on-year change?
  • What is Jupiter Neurosciences quarterly operating income?
  • What is the all time high quarterly operating profit for Jupiter Neurosciences?
  • What is Jupiter Neurosciences quarterly operating profit year-on-year change?
  • What is Jupiter Neurosciences TTM operating income?
  • What is the all time high TTM operating profit for Jupiter Neurosciences?
  • What is Jupiter Neurosciences TTM operating profit year-on-year change?

What is Jupiter Neurosciences annual operaing income?

The current annual operating profit of JUNS is -$3.87 M

What is the all time high annual operating profit for Jupiter Neurosciences?

Jupiter Neurosciences all-time high annual operaing income is -$1.85 M

What is Jupiter Neurosciences annual operating profit year-on-year change?

Over the past year, JUNS annual operaing income has changed by -$438.40 K (-12.77%)

What is Jupiter Neurosciences quarterly operating income?

The current quarterly operating profit of JUNS is -$493.55 K

What is the all time high quarterly operating profit for Jupiter Neurosciences?

Jupiter Neurosciences all-time high quarterly operating income is -$228.80 K

What is Jupiter Neurosciences quarterly operating profit year-on-year change?

Over the past year, JUNS quarterly operating income has changed by +$948.58 K (+65.78%)

What is Jupiter Neurosciences TTM operating income?

The current TTM operating profit of JUNS is -$2.16 M

What is the all time high TTM operating profit for Jupiter Neurosciences?

Jupiter Neurosciences all-time high TTM operating income is -$611.40 K

What is Jupiter Neurosciences TTM operating profit year-on-year change?

Over the past year, JUNS TTM operating income has changed by +$1.98 M (+47.86%)